Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Cheng

Showing results (81-90 of 82) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 82 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 16, 2020
Arginine Depletion Therapy with ADI-PEG20 Limits Tumor Growth in Argininosuccinate Synthase-Deficient Ovarian Cancer, Including Small-Cell Carcinoma of the Ovary, Hypercalcemic TypeJennifer X Ji, Dawn R Cochrane, Basile Tessier-Cloutier, et al.
Cell Metabolism|July 16, 2021
FXR activation protects against NAFLD via bile-acid-dependent reductions in lipid absorptionBethan L Clifford, Leslie R Sedgeman, Kevin J Williams, et al.
Pageof 9

Showing results (81-90 of 82) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 82 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 16, 2020
Arginine Depletion Therapy with ADI-PEG20 Limits Tumor Growth in Argininosuccinate Synthase-Deficient Ovarian Cancer, Including Small-Cell Carcinoma of the Ovary, Hypercalcemic TypeJennifer X Ji, Dawn R Cochrane, Basile Tessier-Cloutier, et al.
Cell Metabolism|July 16, 2021
FXR activation protects against NAFLD via bile-acid-dependent reductions in lipid absorptionBethan L Clifford, Leslie R Sedgeman, Kevin J Williams, et al.
Pageof 9